Product Catalog


CCNA1 / Cyclin-A1 Antibody
| Catalog | Size (Price) | Quantity | In Stock | Operation | Other Information |
| 11013-MM02 |
|
YES |
|
![]() |
|
Cyclin-A1 / CCNA1 Antibody
| Order or Inquire for CCNA1 Antibody product | ![]() |
||
| Detection limit is 4 ng/lane in WB | |||
| Detection limit is 0.0195 ng/well in ELISA |
Cyclin-A1 / CCNA1 Antibody Product Information
| Immunogen : |
Recombinant human CCNA1 protein ( Catalog#11013-H07B ) |
| Antibody Type : | Mouse Monoclonal Antibody ( Mouse mAb Service Platform ) |
|
Clone ID : |
3F6B2C2 |
| Ig Type : |
Mouse IgG2a |
| Formulation : | 0.2 μm filtered solution in PBS with 5% trehalose |
| Preparation : |
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, insect cell-derived, recombinant human CCNA1 ( rh CCNA1 ; Catalog#11013-H07B ; NP_003905.1 ; Met 1 - Gln 465 ). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography |
Cyclin-A1 / CCNA1 Antibody Usage Guide
|
Specificity : |
Human CCNA1 / Cyclin-A1 |
| No cross-reactivity with Baculovirus lysate in ELISA | |
| Western blot : | This antibody can be used at 1 - 2 μg/mL with the appropriate secondary reagents to detect human CCNA1 in WB. Using a DAB detection system, the detection limit for human CCNA1 is approximately 8 ng/lane under non-reducing conditions and 4 ng/lane under reducing conditions |
| Direct ELISA : | This antibody can be used at 0.5 - 1 μg/mL with the appropriate secondary reagents to detect human CCNA1. The detection limit for human CCNA1 is 0.0195 ng/well |
| Storage : | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free. Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles. |
Cyclin-A1 / CCNA1 Antibody Related Products & Topics
Related Areas:
Cancer>>Cell Cycle>>Cyclin>>Cyclin A1/CCNA1
Proteins:
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| Cyclin A1/CCNA1 | Human | Cyclin A1/CCNA1 Protein, Recombinant | 11013-H07B |
Antibodies:
| Molecule | Application | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| Human Cyclin A1/CCNA1 |
WB, ELISA | Cyclin A1/CCNA1 Antibody, Mouse MAb | 11013-MM02 |
Cyclin-A1 / CCNA1 Antibody Background
Cyclin-A1, also known as CCNA1, is a nucleus protein which belongs to the cyclin family and Cyclin AB subfamily. The expression of Cyclin-A1 (CCNA1) is increased in early G1 phase and reaches highest levels during the S and G2/M phases. The mammalian A-type cyclin family consists of two members, Cyclin-A1 (CCNA1) and Cyclin-A2 (CCNA2). CCNA2 promotes both G1/S and G2/M transitions, and targeted deletion of Ccna2 in mouse is embryonic lethal Cyclin-A1 (CCNA1) is expressed in mice exclusively in the germ cell lineage and is expressed in humans at highest levels in the testis and certain myeloid leukaemia cells. Cyclin-A1 (CCNA1) is essential for spermatocyte passage into the first meiotic division in male mice, a function that cannot be complemented by the concurrently expressed B-type cyclins. Cyclin-A1 (CCNA1) may be involved in the control of the cell cycle at the G1/S (start) and G2/M (mitosis) transitions. Cyclin-A1 (CCNA1) may function in the control of the germline meiotic cell cycle and additionally in the control of mitotic cell cycle in some somatic cells. Cyclin-A1 (CCNA1) interacts with the CDK2 and the CDC2 protein kinases to form a serine/threonine kinase holoenzyme complex. The cyclin subunit imparts substrate specificity to the complex
References
- Yang R., et al., 1997, Cancer Res. 57: 913-20.
- Liu, D. et al., 1998, Nat Genet. 20 (4): 377-80.
- Yang R., et al., 1999, Mol. Cell. Biol. 19: 2400-07.
- Diederichs S., et al., 2004, J. Biol. Chem. 279: 33727-41.
+86-400-890-9989






